Showing results (441-450 of 648) with videos related to

Sort By:
Pageof 65
The Biochemical Journal|April 9, 2002
Total direct chemical synthesis and biological activities of human group IIA secretory phospholipase A2Chang-Zhi Dong, Anthony Romieu, Carine M Mounier, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 1994
Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: a potential therapeutic approach in hypertensionM C Fournié-Zaluski, W Gonzalez, S Turcaud, et al.
Journal of Medicinal Chemistry|December 10, 1993
Synthesis and structure-activity studies of a series of [(hydroxybenzyl)amino]salicylates as inhibitors of EGF receptor-associated tyrosine kinase activityH Chen, J Boiziau, F Parker, et al.
Pharmacology, Biochemistry, and Behavior|January 1, 1991
Brain passage of BUBU, a highly selective and potent agonist for delta opioid receptors: in vivo binding and mu versus delta receptors occupancyP Delay-Goyet, M Ruiz-Gayo, A Baamonde, et al.
The Journal of Biological Chemistry|March 28, 1998
The annealing of tRNA3Lys to human immunodeficiency virus type 1 primer binding site is critically dependent on the NCp7 zinc fingers structureE Remy, H de Rocquigny, P Petitjean, et al.
Journal of Neurochemistry|April 5, 2003
Further evidence that the CCK2 receptor is coupled to two transduction pathways using site-directed mutagenesisBlandine Pommier, Cynthia Marie-Claire, Sophie Da Nascimento, et al.
Chembiochem : a European Journal of Chemical Biology|July 1, 2005
Partial protection against Botulinum B neurotoxin-induced blocking of exocytosis by a potent inhibitor of its metallopeptidase activityChristine Anne, Serge Turcaud, Armand G S Blommaert, et al.
Analytical Biochemistry|September 7, 2011
Pluripotentialities of a quenched fluorescent peptide substrate library: enzymatic detection, characterization, and isoenzymes differentiationHervé Poras, Tanja Ouimet, Sou-Vinh Orng, et al.
European Journal of Pharmacology|September 3, 1998
Involvement of delta-opioid receptors in the effects induced by endogenous enkephalins on learned helplessness modelP Tejedor-Real, J A Micó, C Smadja, et al.
British Journal of Pharmacology|April 28, 2001
Enhancement of the effects of a complete inhibitor of enkephalin-catabolizing enzymes, RB 101, by a cholecystokinin-B receptor antagonist in diabetic ratsM A Coudoré-Civiale, M Méen, M C Fournié-Zaluski, et al.
Pageof 65